GOSSAMER BIO INC - NOTE 5.000% 6/0

Historical Holders from Q2 2020 to Q3 2025

Type / Class
Debt / NOTE 5.000% 6/0
All holders as of 30 Sep 2025
Q3 2025
Total 13F principal, excl. options
142,653,005
Holdings value
$120,891,211
% of all portfolios
0%
Number of holders
15
Number of buys
5
Number of sells
-5
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of GOSSAMER BIO INC - NOTE 5.000% 6/0

Period Principal Value Change Price Investors
2025 Q3 142,653,005 $120,891,211 -$3,070,130 $0.695 15
2025 Q2 151,898,880 $94,158,395 -$6,577,623 $0.5247 13
2025 Q1 166,276,850 $106,833,547 -$1,128,807 $0.56 13
2024 Q4 172,449,850 $105,507,106 -$439,375 $0.5399 14
2024 Q3 173,427,850 $91,358,329 -$505,199 $0.5236 14
2024 Q2 174,427,850 $96,670,884 -$752,032 $0.4914 14
2024 Q1 175,927,850 $78,772,359 -$8,738,317,375 $0.4 13
2023 Q4 188,786,978 $70,928,514 +$7,178,077 $0.3746 13
2023 Q3 169,080,828 $75,590,270 +$418,933 $0.3961 14
2023 Q2 168,582,983 $58,393,690 -$2,952,463 $0.3065 14
2023 Q1 198,268,483 $57,344,867 -$3,104,300 $0.2759 18
2022 Q4 210,389,850 $68,739,390 -$6,327,082 $0.3235 18
2022 Q3 217,354,850 $229,093,000 +$9,445,314 $1.03 23
2022 Q2 211,054,350 $162,925,000 -$8,295,107 $0.7475 21
2022 Q1 212,217,850 $182,239,000 -$3,082,458 $0.8087 23
2021 Q4 211,455,850 $219,654,000 -$934,561 $0.98 23
2021 Q3 209,906,850 $217,371,462 +$2,909,827 $1.04 23
2021 Q2 207,953,250 $167,292,324 +$11,943,418 $0.8032 25
2021 Q1 191,143,250 $172,308,584 -$11,653,434 $0.8975 25
2020 Q4 203,806,000 $185,211,000 -$1,432,829 $0.9059 23
2020 Q3 208,056,000 $214,786,000 +$31,360,555 $1.03 28
2020 Q2 171,551,000 $172,861,000 +$172,861,000 $1.01 27